Table 4.
‡ Comparison between patients with and without regional lymph node examination
| Factors | LN Examined
|
§p | |
|---|---|---|---|
| No (%) | Yes (%) | ||
| Female | 132 (48%) | 52 (46%) | 0.65 |
| Age ≥45 | 221 (81%) | 84 (74%) | 0.13 |
| White | 200 (73%) | 94 (82%) | <0.05 |
| Dx Periods | |||
| 1988–1993 | 26 (9%) | 8 (7%) | |
| 1994–1999 | 41 (15%) | 20 (18%) | 0.77 |
| 2000–2005 | 124 (45%) | 49 (43%) | |
| 2006–2010 | 83 (30%) | 37 (32%) | |
| Tumor ≥3 cm | 75 (45%) | 34 (49%) | 0.58 |
| Local Invasion | 36 (14%) | 21 (19%) | 0.23 |
| Metastasis | 4 (2%) | 3 (3%) | 0.45 |
| Radiation | 20 (7%) | 17 (15%) | 0.02 |
| Death | 73 (27%) | 25 (22%) | 0.33 |
‡
Results are expressed as raw number and with percentage in parenthesis. Dx Periods, diagnostic periods; LN, lymph node.
§
X2 test